Dakota Wealth Management purchased a new position in shares of Addus HomeCare Co. (NASDAQ:ADUS – Free Report) during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 1,630 shares of the company’s stock, valued at approximately $217,000.
Other hedge funds have also recently added to or reduced their stakes in the company. Ellsworth Advisors LLC acquired a new position in shares of Addus HomeCare during the second quarter worth approximately $598,000. Quadrature Capital Ltd acquired a new stake in shares of Addus HomeCare in the 1st quarter valued at $1,557,000. Lord Abbett & CO. LLC bought a new stake in shares of Addus HomeCare during the first quarter worth $8,274,000. Vanguard Group Inc. raised its position in shares of Addus HomeCare by 3.2% during the fourth quarter. Vanguard Group Inc. now owns 1,257,440 shares of the company’s stock worth $116,753,000 after acquiring an additional 38,876 shares during the last quarter. Finally, SG Americas Securities LLC acquired a new position in shares of Addus HomeCare during the second quarter valued at $842,000. Institutional investors own 95.35% of the company’s stock.
Addus HomeCare Price Performance
NASDAQ ADUS opened at $128.29 on Tuesday. Addus HomeCare Co. has a one year low of $78.35 and a one year high of $136.12. The firm has a market cap of $2.32 billion, a P/E ratio of 31.83, a P/E/G ratio of 2.33 and a beta of 1.04. The stock’s 50-day moving average is $130.47 and its 200-day moving average is $119.60.
Analyst Upgrades and Downgrades
Several analysts have weighed in on the company. Royal Bank of Canada reissued an “outperform” rating and set a $141.00 price objective on shares of Addus HomeCare in a report on Tuesday, September 3rd. StockNews.com cut shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Sunday, July 7th. TD Cowen increased their price target on Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a research note on Thursday, August 8th. Macquarie reaffirmed an “outperform” rating and set a $139.00 price objective on shares of Addus HomeCare in a research note on Friday, October 11th. Finally, KeyCorp began coverage on Addus HomeCare in a research note on Friday, October 11th. They issued an “overweight” rating and a $150.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, eight have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $131.38.
View Our Latest Stock Analysis on ADUS
Insider Activity at Addus HomeCare
In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of Addus HomeCare stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the sale, the executive vice president now owns 7,215 shares of the company’s stock, valued at $961,687.35. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In related news, Director Esteban Lopez sold 500 shares of the stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total transaction of $63,750.00. Following the completion of the transaction, the director now owns 3,366 shares in the company, valued at approximately $429,165. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Michael D. Wattenbarger sold 21,917 shares of Addus HomeCare stock in a transaction on Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the completion of the sale, the executive vice president now owns 7,215 shares in the company, valued at $961,687.35. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 22,917 shares of company stock valued at $3,050,082. 4.60% of the stock is owned by corporate insiders.
About Addus HomeCare
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Read More
- Five stocks we like better than Addus HomeCare
- What Is WallStreetBets and What Stocks Are They Targeting?
- Inflation Risk Rising, Key Trades Investors Are Making Now
- The Role Economic Reports Play in a Successful Investment Strategy
- 3 Oil Stocks to Watch Before Earnings Come Out
- Are Penny Stocks a Good Fit for Your Portfolio?
- Is American Express Stock’s Sell-the-News Reaction a Buying Opp?
Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Co. (NASDAQ:ADUS – Free Report).
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.